Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 21

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Research Network

Collaboration Network

5 collaborators·10 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Gachon University Gil Medical Center, Incheon, Republic of Korea

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

M Atiqul Haque, PhD

Bangladesh Medical University

Moderately Similar
1 trials

Shared therapeutic areas:

Increased Drug Resistance
Similarity Score30%

Peter Kertes, MD, FRCSC

Sunnybrook Health Sciences Centre

Moderately Similar
1 trials

Shared therapeutic areas:

Increased Drug Resistance
Similarity Score30%

Norton Perez, MD

Cooperative University of Colombia

Moderately Similar
3 trials

Shared therapeutic areas:

Increased Drug Resistance
Similarity Score30%

Vivian T Yin, MD

University of Toronto

Moderately Similar
1 trials

Shared therapeutic areas:

Increased Drug Resistance
Similarity Score30%

David R West, PhD

University of Colorado, Denver

Moderately Similar
1 trials

Shared therapeutic areas:

Increased Drug Resistance
Similarity Score30%

Robert C Block, MD, MPH

University of Rochester

Moderately Similar
2 trials

Shared therapeutic areas:

Increased Drug Resistance
Similarity Score30%

Daniel Weisbrod, MD, FRCSC

Sunnybrook Health Sciences Centre

Moderately Similar
1 trials

Shared therapeutic areas:

Increased Drug Resistance
Similarity Score30%

Ki Hyeong Lee, MD, Ph.D

Chungbuk National University Hospital, Cheongju-si, Chungcheongbuk-do, Republic of Korea

Related
1 trials

Shared therapeutic areas:

Increased Drug Resistance

Worked with same sponsors:

Hanmi Pharmaceutical Company LimitedNational OncoVenture
Collaborated on 1 trial
Similarity Score14%

Ji-Youn Han, MD. Ph.D

National Cancer Center, Goyang-si, Gyeonggi-do, Republic of Korea,Asan Medical Center, Songpa-gu, Seoul, Republic of Korea,

Related
1 trials

Shared therapeutic areas:

Increased Drug Resistance

Worked with same sponsors:

Hanmi Pharmaceutical Company LimitedNational OncoVenture
Collaborated on 1 trial
Similarity Score14%

Young Joo Min, MD, Ph.D

Ulsan University Hospital, Dong-gu, Ulsan, Republic of Korea

Related
1 trials

Shared therapeutic areas:

Increased Drug Resistance

Worked with same sponsors:

Hanmi Pharmaceutical Company LimitedNational OncoVenture
Collaborated on 1 trial
Similarity Score14%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT01718847Phase 2PrincipalInvestigator

NOV120101 Phase 2 Study in NSCLC Patients With Aquired Resistance to 1st Generation EGFR Tyrosine Kinase Inhibitors

Increased Drug Resistance
Completed

All 1 trials loaded